# Pharmacokinetics of Metformin Intolerance

> **NCT03361878** · PHASE4 · COMPLETED · sponsor: **NHS Tayside** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Metformin Adverse Reaction

## Interventions

- **DRUG:** Metformin Hydrochloride

## Key facts

- **NCT ID:** NCT03361878
- **Lead sponsor:** NHS Tayside
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-04
- **Primary completion:** 2016-05-05
- **Final completion:** 2016-05-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03361878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03361878, "Pharmacokinetics of Metformin Intolerance". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03361878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*